-
US House passes spending bill ending government shutdown
-
US jet downs Iran drone but talks still on course
-
UK police launching criminal probe into ex-envoy Mandelson
-
US-Iran talks 'still scheduled' after drone shot down: White House
-
Chomsky sympathized with Epstein over 'horrible' press treatment
-
French prosecutors stick to demand for five-year ban for Le Pen
-
Russia's economic growth slowed to 1% in 2025: Putin
-
Bethell spins England to 3-0 sweep over Sri Lanka in World Cup warm-up
-
Nagelsmann backs Ter Stegen for World Cup despite 'cruel' injury
-
Homage or propaganda? Carnival parade stars Brazil's Lula
-
EU must be 'less naive' in COP climate talks: French ministry
-
Colombia's Petro meets Trump after months of tensions
-
Air India inspects Boeing 787 fuel switches after grounding
-
US envoy evokes transition to 'democratic' Venezuela
-
Syria govt forces enter Qamishli under agreement with Kurds
-
WHO wants $1 bn for world's worst health crises in 2026
-
France summons Musk, raids X offices as deepfake backlash grows
-
Four out of every 10 cancer cases are preventable: WHO
-
Sacked UK envoy Mandelson quits parliament over Epstein ties
-
US House to vote Tuesday to end partial government shutdown
-
Eswatini minister slammed for reported threat to expel LGBTQ pupils
-
Pfizer shares drop on quarterly loss
-
Norway's Kilde withdraws from Winter Olympics
-
Vonn says 'confident' can compete at Olympics despite ruptured ACL
-
Germany acquires power grid stake from Dutch operator
-
Finland building icebreakers for US amid Arctic tensions
-
Petro extradites drug lord hours before White House visit
-
Disney names theme parks boss chief Josh D'Amaro as next CEO
-
Macron says work under way to resume contact with Putin
-
Prosecutors to request bans from office in Le Pen appeal trial
-
Tearful Gazans finally reunite after limited Rafah reopening
-
Iran president confirms talks with US after Trump's threats
-
Spanish skater allowed to use Minions music at Olympics
-
Fire 'under control' at bazaar in western Tehran
-
Howe trusts Tonali will not follow Isak lead out of Newcastle
-
Vonn to provide injury update as Milan-Cortina Olympics near
-
France summons Musk for 'voluntary interview', raids X offices
-
US judge to hear request for 'immediate takedown' of Epstein files
-
Russia resumes large-scale strikes on Ukraine in glacial temperatures
-
Fit-again France captain Dupont partners Jalibert against Ireland
-
French summons Musk for 'voluntary interview' as authorities raid X offices
-
IOC chief Coventry calls for focus on sport, not politics
-
McNeil's partner hits out at 'brutal' football industry after Palace move collapses
-
Proud moment as Prendergast brothers picked to start for Ireland
-
Germany has highest share of older workers in EU
-
Teen swims four hours to save family lost at sea off Australia
-
Ethiopia denies Trump claim mega-dam was financed by US
-
Russia resumes strikes on freezing Ukrainian capital ahead of talks
-
Malaysian court acquits French man on drug charges
-
Switch 2 sales boost Nintendo results but chip shortage looms
| RYCEF | 1.65% | 16.95 | $ | |
| CMSC | -0.44% | 23.645 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| RBGPF | 0.12% | 82.5 | $ | |
| GSK | 1.43% | 53.23 | $ | |
| NGG | 1.78% | 86.14 | $ | |
| BCC | 3.41% | 84.64 | $ | |
| RIO | 3.77% | 96.146 | $ | |
| CMSD | -0.71% | 23.91 | $ | |
| BTI | 1.25% | 61.765 | $ | |
| VOD | 2.13% | 15.235 | $ | |
| BCE | 1.36% | 26.185 | $ | |
| RELX | -16.55% | 30.485 | $ | |
| AZN | -2.56% | 183.7 | $ | |
| JRI | -0.38% | 13.1 | $ | |
| BP | 2.81% | 38.79 | $ |
US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
L.E.Campos--PC